Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Evaluation of the Spiracur SNaP™ Wound Care System for Treatment of Skin Cancer Excision Sites and Split Thickness Skin Grafts

NCT01349894 is registered in ClinicalTrials.gov with Solventum US LLC as lead sponsor.

NCT NCT01349894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Evaluation of the Spiracur SNaP™ Wound Care System for Treatment of Skin Cancer Excision Sites and Split Thickness Skin Grafts
Lead sponsor
Solventum US LLC
Phase
Observational
Overall status
Withdrawn
Start date
August 31, 2011
Completion date
June 30, 2012
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin cancer excision site, skin graft, split thickness skin graft